Drug discovery > Target Discovery Products & Reviews

Our LC-MS capabilities offer a flexible service from discovery, through to regulated GLP preclinical and GCP clinical studies.

Connect with our integrated solutions to support your cell therapy development at every stage. Through our high-quality materials and services, our goal is to support your research through every phase: from initial discovery through clinical trials to commercially viable cell therapies.  

Forge an innovative path towards a cure by tapping into our decades of experience in delivering gene therapy solutions that can help you navigate obstacles and challenges. Our end-to-end solutions, high-quality products, and unrivaled services are here to support you at every step of the way, from gene therapy research to gene therapy commercialization.  

Advancements in stem cell therapy continue to shed light on how stem cells may be used in various clinical applications, which include cell replacement therapies, immunomodulatory therapies, and many others. Whether you’re developing an induced pluripotent stem cell therapy or adult stem cell therapy, Thermo Fisher Scientific has the solutions to advance your research to the clinic and beyond. Advancing your stem cell therapy…

With the recent surge of T cell–based immunotherapies, more researchers are taking interest in these specialized immune cells, particularly with respect to the development of chimeric antigen receptor T cell (CAR-T) therapies. Whether you’re developing a CAR-T therapy, another type of T cell immunotherapy, or working with other immune cell types, we can help you move from research to the clinic and beyond. Our cell culture med…

The recent advances in cell and gene therapy have led to the need for more cost-effective and scalable lentiviral vector (LV vector) manufacturing platforms. Lentiviral vector gene therapy is now widely used because of its use in advanced clinical trials and regulatory-approved therapies in combination with technological improvements in characterization and safety profiling. As a world leader in serving science, the innovative…

The iLite® Fc Effector Reporter Gene Bioassays Portfolio offers a variety of reporter gene cell lines and target cells that can be used in MOA-reflective assays to measure the Fc effect of antibodies and other biologics that specifically bind and activate Fc receptors. Using a Luciferase reporter gene system offers a convenient and powerful way of measuring antibodies' in vitro efficacy in triggering ADCC and ADCP.

In diagnosis of Rheumatoid Arthritis (RA), the measurement of anti-CCP is integral. People who test positive for Anti-CCP, are very likely to develop or have already developed RA, but not all who have RA, necessarily develop anti-CCP. Early detection of RA is crucial for reducing tissue damage.

Specifically formulated for superior expansion of human natural killer (hNK) cells for cell therapy applications

First commercially available, defined, serum-free medium (SFM) for the proliferation and/or manipulation of T cells and dendritic cells manufactured in compliance with cGMP

Classical Dulbecco’s phosphate buffered saline that contains calcium and magnesium but no phenol red

Animal origin free (AOF) dipeptide alternative to L-glutamine, with increased stability that improves cell health

GMP-manufactured Cas9 protein for clinical research

Next-generation CRISPR Cas9 protein engineered to deliver maximum editing efficiency

Myco-BlueTM Mycoplasma Detector is a rapid detection reagent for mycoplasma contamination in cell cultures. Its core is Vazyme's unique isothermal amplification technology. Myco-BlueTM Mycoplasma Detector is very easy to use, just add 1 μl of cell culture supernatant to the reaction system and incubate at 60°C for 1 h. If the cell culture is contaminated by mycoplasma, the conservative sequence of mycoplasma DNA will be specif…

Native human C5 is a naturally glycosylated (1.6%) polypeptide containing two disulfide-linked chains. C5 is essential for formation of the membrane attack complex (MAC) and is activated by all three pathways of complement activation.

CD Genomics provides complete plasmid DNA sequencing service, and their improved bioinformatics pipelines are available to perform de novo assembly with no reference required.

Automation for immunohistochemistry methods, FISH and CISH

The next generation of RNP reagents

Recombinant antigens and lentivirus for emerging SARS-CoV-2 variants

Readily available plasma that can be customized to your specifications.

a revolutionary mass spectrometry technology that defines a new architecture for the front end of a mass spectrometer.

High-throughput immuno-analyzer that enables simultaneous testing for various parameters

The Cocoon ® Platform streamlines patient-scale cell therapy manufacturing for greater efficiency and reliability. Automated, closed, and flexible, this end-to-end cell manufacturing platform gives you increased control over your specific process.

BL21 Competent E. coli is a widely used non-T7 expression E. coli strain and is suitable for transformation and protein expression. This strain does not express the T7 RNA Polymerase. Ideal for Plac, Ptac, Ptrc ParaBAD expression vectors Protease deficient No dry ice surcharge on competent cell shipments Outgrowth medium included Free of animal products